Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients

NCT07743060 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Benign Prostatic Hyperplasia
Silodosin
Tamsulosin
Choroid
Iris Disease
Tomography, Optical Coherence

Interventions

DRUG: tamsulosin 0.4mg
DRUG: Silodosin 8 mg

Sponsor

Mohsen Pourazizi